Abstracts tagged "anti-TNF therapy and Golimumab"

Abstract Number: 1477 • ACR/ARP Annual Meeting 2019
Golimumab Improves Direct Costs of Healthcare Utilization and Indirect Costs Within Patients with RA, PsA, and as – Analysis of a Non-Interventional Study in Germany
Klaus Krüger ¹, Gerd Burmester ², Siegfried Wassenberg ³, Astrid Thiele ⁴ and Matthias Thomas⁵, ¹Medical Centre of Rheumatology, Munich, Germany, ²Charité—University Medicine Berlin, Berlin, Germany, ³Centre of Rheumatology, Ratingen, Germany, ⁴Krankenhaus St. Josef Wuppertal, Wuppertal, Germany, ⁵MSD Sharp & Dohme GmbH, Haar, Germany
Background/Purpose: Rheumatic diseases are associated with pain, loss of functionality, fatigue, hospitalization, sick leave, and work disability. This results in high economic burden for patients…